Medico Remedies Ltd.

BSE: 540937 SECTOR: Pharmaceuticals & Drugs  2214   5   0

141.90
-7.45 (-4.99%)
BSE: 30 Nov 4:00 PM

Price Summary

Today's High

₹ 141.9

Today's Low

₹ 141.9

52 Week High

₹ 149.35

52 Week Low

₹ 0

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

235.51 Cr.

Enterprise Value

247.73 Cr.

No. of Shares

1.66 Cr.

P/E

90.9

P/B

5.24

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  27.06

CASH

2.83 Cr.

DEBT

15.05 Cr.

Promoter Holding

73.34 %

EPS (TTM)

₹  1.56

Sales Growth

38.08%

ROE

8.32 %

ROCE

10.1%

Profit Growth

58.96 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year38.08%
3 Year26.11%
5 Year12.91%

Profit Growth

1 Year58.96%
3 Year28.54%
5 Year18.06%

ROE%

1 Year8.32%
3 Year6.55%
5 Year7.16%

ROCE %

1 Year10.1%
3 Year8.51%
5 Year8.8%

Debt/Equity

0.4638

Price to Cash Flow

90.3

Interest Cover Ratio

4.99856327263559

CFO/PAT (5 Yr. Avg.)

1.20335328129083

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2021 73.34 0
Mar 2021 73.34 12.94
Sep 2020 73.34 0
Mar 2020 73.34 0
Sep 2019 73.34 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 26.107530802076% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of 6.4510211982945 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.20335328129083.
  • The company has a high promoter holding of 73.34%.

 Limitations

  • Company has a poor ROE of 6.54950287809952% over the past 3 years.
  • The company is trading at a high EV/EBITDA of 39.58.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 54.42 61.02 97.69 88.64 122.39
Total Expenditure 50.41 57.54 94.93 85.8 117.16
Operating Profit 4.01 3.48 2.76 2.84 5.23
Other Income 0.36 0.91 1.9 2.1 1.03
Interest 1.33 1.52 0.98 1.06 0.92
Depreciation 1.05 1 1.51 1.66 1.65
Exceptional Items -0.3 0 0 0 0
Profit Before Tax 1.69 1.87 2.18 2.22 3.69
Tax 0.06 0.65 0.6 0.58 1.09
Net Profit 1.63 1.22 1.57 1.63 2.59
Adjusted EPS (Rs.) 1.27 0.74 0.95 0.98 1.56

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 3.2 4.15 4.15 4.15 4.15
Total Reserves 13.17 22.52 24.09 25.72 28.31
Borrowings 10.84 2.19 2.37 4.71 4.95
Other N/C liabilities 0.09 0.36 0.25 0.22 0.26
Current liabilities 21.11 30.17 45.45 40.48 38.8
Total Liabilities 48.41 59.39 76.31 75.27 76.47
Assets
Net Block 6.84 6.63 12.27 12.55 15.31
Capital WIP 2.76 4.37 0.9 2.28 0
Intangible WIP 0 0 0 0 0
Investments 0.29 0.24 0.15 0.15 0.11
Loans & Advances 0.36 2.46 3.77 3.59 1.66
Other N/C Assets 0 0 0.05 0.06 0
Current Assets 38.16 45.69 59.18 56.64 59.39
Total Assets 48.41 59.39 76.31 75.27 76.47
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 1.69 1.87 2.18 2.22 3.69
Adjustment 2.46 2.15 1.86 2.14 1.84
Changes in Assets & Liabilities -6.56 1.64 1.49 -2.81 -1.74
Tax Paid -0.49 -0.55 -0.55 -0.54 -1.15
Operating Cash Flow -3.22 5.1 4.94 0.97 2.61
Investing Cash Flow -2.81 -4.98 -4.43 -3.08 -0.08
Financing Cash Flow 5.8 -0.62 -0.55 2.6 -0.35
Net Cash Flow -0.23 -0.5 -0.04 0.48 2.18

Corporate Actions

Investors Details

PARTICULARS Sep 2019% Mar 2020% Sep 2020% Mar 2021% Sep 2021%
Promoters 73.34 73.34 73.34 73.34 73.34
haresh k mehta 16.56 16.56 16.56 16.56 16.56
haresh k mehta huf... - - 11.90 11.90 11.90
haresh k mehta huf 11.90 11.90 - - -
rita haresh mehta 10.40 10.40 - - -
rita haresh mehta . - - 10.40 10.40 10.40
rishit hareshbhai ... 9.49 9.49 9.49 9.49 9.49
harshit haresh meh... 9.11 9.11 9.11 9.11 9.11
shweta harshit meh... - - 8.75 8.75 8.75
shweta harshit meh... 8.75 8.75 - - -
priyal rishit mehta 6.27 6.27 - - -
priyal rishit meht... - - 6.27 6.27 6.27
harshit h mehta hu... - - 0.87 0.87 0.87
harshit h mehta huf 0.87 0.87 - - -
PARTICULARS Sep 2019% Mar 2020% Sep 2020% Mar 2021% Sep 2021%
Investors 26.66 26.66 26.66 26.66 26.66
nopea capital serv... 4.86 4.89 - - 3.41
nopea capital serv... - - 4.63 4.66 -
overskud multi ass... 4.71 2.40 - - -
overskud multi ass... - - 1.36 - -
emrald commercial ... 3.35 3.88 3.88 4.54 4.54
aryaman capital ma... - - 1.71 1.19 -
aryaman capital ma... 1.07 - - - -
shri parasram hold... 4.02 - - - -
s k growth fund pv... - - - 3.88 4.02
shri ravindra medi... - 3.96 - - -
shri ravindra medi... - - 3.24 - -
venkateshwara indu... - - 3.18 3.18 -
goodpoint commodea... 3.18 3.18 - - -
venkateshwara indu... - - - - 3.18
escorp asset manag... - - - - 3.07
vijaygopal parasra... - - - 2.83 -
aryaman capital ma... - 1.76 - - -
sanjay narendra ba... - - 1.50 1.50 -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Medico Remedies Stock Price Analysis and Quick Research Report. Is Medico Remedies an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Medico Remedies and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 2.6080845 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Medico Remedies has a Debt to Equity ratio of 0.4638 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Medico Remedies , the EPS growth was 58.9647010917975 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Medico Remedies has OPM of 4.27192125965035 % which is a bad sign for profitability.
     
  • ROE: Medico Remedies have a poor ROE of 8.31673447008795 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Medico Remedies

X